1. Home
  2. WDS vs IQV Comparison

WDS vs IQV Comparison

Compare WDS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Woodside Energy Group Limited

WDS

Woodside Energy Group Limited

HOLD

Current Price

$24.69

Market Cap

31.8B

Sector

Energy

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$164.11

Market Cap

27.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDS
IQV
Founded
1954
1982
Country
Australia
United States
Employees
N/A
93000
Industry
Oil & Gas Production
Biotechnology: Commercial Physical & Biological Resarch
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.8B
27.9B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
WDS
IQV
Price
$24.69
$164.11
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$230.56
AVG Volume (30 Days)
1.5M
1.6M
Earning Date
02-23-2026
05-05-2026
Dividend Yield
4.53%
N/A
EPS Growth
N/A
4.67
EPS
N/A
7.84
Revenue
N/A
$9,739,000,000.00
Revenue This Year
N/A
$6.77
Revenue Next Year
$14.21
$5.87
P/E Ratio
$11.81
$21.56
Revenue Growth
N/A
41.60
52 Week Low
$11.26
$134.65
52 Week High
$25.19
$247.05

Technical Indicators

Market Signals
Indicator
WDS
IQV
Relative Strength Index (RSI) 71.95 39.18
Support Level $15.00 $157.59
Resistance Level $25.19 $166.38
Average True Range (ATR) 0.55 5.58
MACD 0.02 1.21
Stochastic Oscillator 87.84 16.20

Price Performance

Historical Comparison
WDS
IQV

About WDS Woodside Energy Group Limited

Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: